Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.36 |
| ▸ | PRKCG | P05129 | 3/20 | 0.36 |
| ▸ | PRKCB | P05771 | 3/20 | 0.36 |
| ▸ | PRKCA | P17252 | 3/20 | 0.36 |
| ▸ | PRKCH | P24723 | 3/20 | 0.36 |
| ▸ | PRKCI | P41743 | 3/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.36 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.35 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17526806 | 0.94 | DNM1 (0.43) | DNM1CA1CA2PRKD3PRKCG | |
| SCHEMBL27826098 | 0.94 | DNM1 (0.43) | DNM1CA1CA2PRKD3PRKCG | |
| SCHEMBL14183044 | 0.94 | DNM1 (0.38) | DNM1CA1CA2PRKD3PRKCG | |
| SCHEMBL17527008 | 0.94 | DNM1 (0.43) | DNM1CA1CA2PRKD3PRKCG | |
| SCHEMBL17526680 | 0.92 | DNM1 (0.48) | DNM1CA2PRKD3PRKCGPRKCB | |
| SCHEMBL16317815 | 0.92 | DNM1 (0.48) | DNM1CA2PRKD3PRKCGPRKCB | |
| SCHEMBL17526936 | 0.92 | DNM1 (0.48) | DNM1CA2PRKD3PRKCGPRKCB | |
| SCHEMBL1142232 | 0.92 | DNM1 (0.48) | DNM1CA2PRKD3PRKCGPRKCB | |
| SCHEMBL14520047 | 0.88 | TSHR (0.44) | DNM1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL13464149 | 0.88 | TSHR (0.44) | DNM1PRKD3PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0988919-B1 | Screen printable and dispensable active brazing paste and its method of manufacturing | ENDRESS HAUSER GMBH CO (DE) | 2003-10-29 | — | — | EP | claimed |
| US-6156130-A | Screen-printable or dispensable active brazing pastes and process for producing the same | ENDRESS + HAUSER GMBH + CO. (DE) | 2000-12-05 | — | — | US | claimed |
| EP-0988919-A1 | Screen printable and dispensable active brazing paste and its method of manufacturing | Endress u. Hauser GmbH u.Co. (DE) | 2000-03-29 | — | — | EP | claimed |
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | S&T GLOBAL INC. (US) | 2016-02-11 | — | — | US | disclosed |
| WO-2012035346-A1 | PRODRUGS OF GUANFACINE | SHIRE, LLC (US) | 2012-03-22 | — | — | WO | disclosed |
| WO-2011033296-A1 | PRODRUGS OF GUANFACINE | SHIRE LLC (US) | 2011-03-24 | — | — | WO | disclosed |
| EP-0988919-B1 | Screen printable and dispensable active brazing paste and its method of manufacturing | ENDRESS HAUSER GMBH CO (DE) | 2003-10-29 | — | — | EP | disclosed |
| US-6156130-A | Screen-printable or dispensable active brazing pastes and process for producing the same | ENDRESS + HAUSER GMBH + CO. (DE) | 2000-12-05 | — | — | US | disclosed |
| US-6156130-A | Screen-printable or dispensable active brazing pastes and process for producing the same | ENDRESS + HAUSER GMBH + CO. (DE) | 2000-12-05 | — | — | US | disclosed |
| JP-2000094180-A | ACTIVATED BRAZING FILLER METAL PASTE CAPABLE OF SCREEN PRINTING, MANUFACTURE OF THE SAME, MANUFACTURE OF ACTIVATED BRAZING FILLER METAL-BONDING, AND METHOD FOR BRAZING WITH ACTIVATED BRAZING FILLER METAL | ENVEC MESS & REGELTECHNIK GMBH & CO | 2000-04-04 | — | — | JP | disclosed |
| EP-0988919-A1 | Screen printable and dispensable active brazing paste and its method of manufacturing | Endress u. Hauser GmbH u.Co. (DE) | 2000-03-29 | — | — | EP | disclosed |
| EP-0988919-A1 | Screen printable and dispensable active brazing paste and its method of manufacturing | Endress u. Hauser GmbH u.Co. (DE) | 2000-03-29 | — | — | EP | disclosed |
| US-4456471-A | PREEMERGENCE HERBICIDE FOR GRASSES | CHEVRON RESEARCH COMPANY (US) | 1984-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | FKBP1B, MALT1, FKBP5 | DNM1 3016/4885CA1 4107/4885CA2 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.